Neurocrine/$NBIX
About Neurocrine
Ticker
Industry
Employees
Neurocrine Metrics
$15B
38.43
$3.73
0.35
-
Price and volume
Market cap
$15B
Beta
0.35
52-week high
$157.98
52-week low
$110.95
Average daily volume
967K
Financial strength
Current ratio
4.367
Quick ratio
3.977
Long term debt to equity
9.246
Total debt to equity
10.526
Interest coverage (TTM)
130.93%
Management effectiveness
Return on assets (TTM)
11.79%
Return on equity (TTM)
16.35%
Valuation
Price to earnings (TTM)
38.429
Price to revenue (TTM)
6.389
Price to book
5.33
Price to tangible book (TTM)
5.41
Price to free cash flow (TTM)
32.56
Growth
Revenue change (TTM)
25.72%
Earnings per share change (TTM)
97.40%
3-year revenue growth (CAGR)
28.00%
3-year earnings per share growth (CAGR)
-6.38%
What the Analysts think about Neurocrine
Analyst Ratings
Neurocrine Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
Neurocrine Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
Neurocrine News
What’s the current market cap for Neurocrine stock?
What is the P/E ratio for Neurocrine stock?
Does Neurocrine stock pay dividends?
No, Neurocrine (NBIX) stock does not pay dividends to its shareholders as of January 21, 2025.
When is the next Neurocrine dividend payment date?
Neurocrine (NBIX) stock does not pay dividends to its shareholders.
What is the beta indicator for Neurocrine?
Neurocrine (NBIX) has a beta rating of 0.35. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.